Every article, report, and earnings note where TWST appears.
Twist Bioscience Corporation (TWST) rose after a mixed quarter that featured an EPS miss but a revenue beat, continued sequential growth, and improving segment momentum. This deep dive examines the margin expansion, adjusted EBITDA breakeven path, and why investors focused on the bigger operating picture.
Twist Bioscience Corporation (TWST) rises after reporting earnings misses, with shares up 5.5% as investors react to the latest quarterly results.
Twist Bioscience posted 19.3% revenue growth in fiscal Q2 2026 and raised full-year guidance, but it still faces losses and a demanding valuation. The stock earns a Hold as execution improves while investors wait for profitability.
Twist Bioscience Corporation (TWST) drops despite revenue growth and raised guidance, as a wider-than-expected EPS loss overshadowed strong segment momentum, margin improvement, and continued sequential sales gains. This deep-dive breaks down the earnings miss, operating trends, and why investors focused on profitability over the top-line beat.
Twist Bioscience Corporation (TWST) drops 5.5% after reporting earnings misses, as investors react to weaker-than-expected results and reassess the stock's near-term outlook.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate TWST ReportCancel anytime